Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

相似書籍

• Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial
  由: Erin M. Guest, et al.
  出版: (2022-02-01)
• Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1
  由: Kelly E. Faulk, et al.
  出版: (2026-01-01)
• Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group AALL1331 trial
  由: Laura E. Hogan, et al.
  出版: (2025-06-01)
• SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731
  由: Caitlin W. Elgarten, et al.
  出版: (2023-08-01)
• 535 Multiomic analysis of KMT2A-r pediatric acute myeloid leukemia
  由: Trenton Edwards, et al.
  出版: (2025-04-01)